Search bioRxiv⌕ Search

Biology subjects

Garrett-Larsen, J.

Publications and source records attributed to Garrett-Larsen, J..

3 recordsLinked to original sources

Infected host competence overshadows heterogeneity in susceptibility in shaping experimental epizootics

The accelerated rate of disease emergence in recent decades underscores the need to understand conditions that promote or dampen epidemics. Theoretical models consistently show that epidemics are smaller in populations with higher among-individual heterogeneity in susceptibility. Experimental tests of these predictions are rare but critical for understanding how heterogeneity in susceptibility shapes epidemics in natural systems. We directly link data-parameterized models from previous dose response experiments in the house finch and Mycoplasma gallisepticum system to experimental epidemics in replicated aviary mesocosm flocks. We manipulated flock-level heterogeneity in susceptibility by seeding epidemics in flocks composed of either pathogen-naive or previously exposed birds, which prior work showed have higher heterogeneity in susceptibility relative to pathogen-naive populations. We tracked epidemics for over two months, combining empirical data and stochastic compartmental models to address how heterogeneity in susceptibility changes epidemic severity. Consistent with previous work, estimates of heterogeneity in susceptibility based on coefficients of variation were higher for flocks given prior pathogen exposure relative to pathogen-naive flocks. However, in contrast with prior work on individually-housed birds which showed relatively homogeneous susceptibility for pathogen-naive birds, the pathogen-naive flocks in this study were better described by heterogeneous, rather than homogenous, models of susceptibility. This suggests that flock-level epidemics captured sources of heterogeneity absent in controlled experiments, such as transmission heterogeneity. Finally, although prior exposure conferred protection from disease at the individual level, we did not detect predicted effects of prior exposure and its associated flock-level heterogeneity on prevalence. However, our ability to detect effects of prior exposure on flock-level prevalence was obscured by unexpected variation in the competence of the initially pathogen-naive index birds that seeded each epidemic. This variation in infectiousness among index birds significantly predicted flock-level prevalence, with low index bird infectiousness contributing to the absence of detectable epidemics in two of the three naive flocks. Our stochastic simulations generated a wide range of prevalence outcomes for small epidemics over the timescales examined, further underscoring the challenges of measuring transmission dynamics in naturalistic settings, where unexpected variation in host traits such as competence can obscure other factors of interest. Open research statementData are not yet provided. Data and code will be permanently and publicly archived in the Virginia Tech Data Repository if the paper is accepted for publication

ecology↗

Prior exposure to pathogens augments host heterogeneity in susceptibility and has key epidemiological consequences

Pathogen epidemics are key threats to human and wildlife health. Across systems, host protection from pathogens following initial exposure is often incomplete, resulting in recurrent epidemics through partially-immune hosts. Variation in population-level protection has important consequences for epidemic dynamics, but how acquired protection influences inter{-}individual heterogeneity in susceptibility and its epidemiological consequences remains understudied. We experimentally investigated whether prior exposure (none, low-dose, or high{-}dose) to a bacterial pathogen alters host heterogeneity in susceptibility among songbirds. Hosts with no prior pathogen exposure had little variation in protection, but heterogeneity in susceptibility was significantly augmented by prior pathogen exposure, with the highest variability detected in hosts given high-dose prior exposure. An epidemiological model parameterized with experimental data found that heterogeneity in susceptibility from prior exposure more than halved epidemic sizes compared with a homogeneous population with identical mean protection. However, because infection-induced mortality was also greatly reduced in hosts with prior pathogen exposure, reductions in epidemic size were smaller than expected in hosts with prior exposure. These results highlight the importance of variable protection from prior exposure and/or vaccination in driving population-level heterogeneity and epidemiological dynamics.

microbiology↗

Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer

The immunosuppressive milieu in pancreatic cancer (PC) is a significant hurdle to treatments, resulting in survival statistics that have barely changed in 5 decades. Here we present a combination treatment consisting of stereotactic body radiation therapy (SBRT) and IL-12 mRNA lipid nanoparticles delivered directly to pancreatic murine tumors. This treatment was effective against primary and metastatic models, achieving cures in both settings. IL-12 protein concentrations were transient and localized primarily to the tumor. Depleting CD4 and CD8 T cells abrogated treatment efficacy, confirming they were essential to treatment response. Single cell RNA sequencing from SBRT/IL-12 mRNA treated tumors demonstrated not only a complete loss of T cell exhaustion, but also an abundance of highly proliferative and effector T cell subtypes. SBRT elicited T cell receptor clonal expansion, whereas IL-12 licensed these cells with effector function. This is the first report demonstrating the utility of SBRT and IL-12 mRNA in PC. Statement of significanceThis study demonstrates the use of a novel combination treatment consisting of radiation and immunotherapy in murine pancreatic tumors. This treatment could effectively treat local and metastatic disease, suggesting it may have the potential to treat a cancer that has not seen a meaningful increase in survival in 5 decades.

cancer biology↗